0001003642-17-000012.txt : 20170227
0001003642-17-000012.hdr.sgml : 20170227
20170227202321
ACCESSION NUMBER: 0001003642-17-000012
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170226
FILED AS OF DATE: 20170227
DATE AS OF CHANGE: 20170227
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMPAX LABORATORIES INC
CENTRAL INDEX KEY: 0001003642
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 650403311
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 30831 HUNTWOOD AVENUE
CITY: HAYWARD
STATE: CA
ZIP: 94544
BUSINESS PHONE: 510-240-6000
MAIL ADDRESS:
STREET 1: 30831 HUNTWOOD AVENUE
CITY: HAYWARD
STATE: CA
ZIP: 94544
FORMER COMPANY:
FORMER CONFORMED NAME: GLOBAL PHARMACEUTICAL CORP \DE\
DATE OF NAME CHANGE: 19951117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Reasons Bryan M.
CENTRAL INDEX KEY: 0001553489
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34263
FILM NUMBER: 17644341
MAIL ADDRESS:
STREET 1: C/O IMPAX LABORATORIES, INC.
STREET 2: 30831 HUNTWOOD AVENUE
CITY: HAYWARD
STATE: CA
ZIP: 94544
4
1
wf-form4_148824498735141.xml
FORM 4
X0306
4
2017-02-26
0
0001003642
IMPAX LABORATORIES INC
IPXL
0001553489
Reasons Bryan M.
C/O IMPAX LABORATORIES, INC.
30831 HUNTWOOD AVENUE
HAYWARD
CA
94544
0
1
0
0
Chief Financial Officer
Common Stock
2017-02-26
4
F
0
5715
14.05
D
81781
D
These shares of common stock were withheld by the issuer upon the vesting of two restricted stock awards to satisfy Mr. Reasons' payroll tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.
/s/ Mark A. Schlossberg, by Power of Attorney
2017-02-27